New CAR-T therapy shows promise for Tough-to-Treat blood cancers
NCT ID NCT06014762
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 29 times
Summary
This early-stage study is testing a new type of cell therapy called P-CD19CD20-ALLO1 for people with certain B-cell cancers (like diffuse large B-cell lymphoma) that have come back or not responded to standard treatments. The therapy uses donor immune cells that are specially designed to target and kill cancer cells. The main goal is to check the safety of this treatment and find the best dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DLBCL - DIFFUSE LARGE B CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Advent Health Orlando
Orlando, Florida, 32803, United States
-
Baylor Scott & White Research Institute
Dallas, Texas, 75204, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Loma Linda University Cancer Center
Loma Linda, California, 92354, United States
-
NYU Grossman School of Medicine
New York, New York, 10016, United States
-
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Our Lady of the Lake Hospital
Baton Rouge, Louisiana, 70808, United States
-
Pennsylvania State University
Hershey, Pennsylvania, 17033, United States
-
Prisma Health - Upstate Cancer Institute
Greenville, South Carolina, 29605, United States
-
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, 27599, United States
-
University of Cincinnati
Cincinnati, Ohio, 45206, United States
-
University of Oklahoma, Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Wayne State - Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
Conditions
Explore the condition pages connected to this study.